Softmax Co., Ltd
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Softmax Co., Ltd's yearly results (2022–2025), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 13.3 times. Higher than 98% of Healthcare companies in Japan.
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 92% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥85Over the last 3 years, every ¥100 of reported profit came with ¥85 of operating cash.
Lower than 84% of Healthcare companies in Japan.
Self-Funding Ratio
13.3×Over the last 3 years its own operating cash covered its investment spending (capex) 13.3 times.
Higher than 98% of Healthcare companies in Japan.
Cash Locked Ratio
¥4For every ¥100 of sales, ¥4 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥2 tied up three years earlier.
Less money tied up than 73% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 92% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥8Sales grew 37% in 3 years; of every extra ¥100 of sales, ¥8 became extra profit.
Higher than 58% of Healthcare companies in Japan.
Asset Productivity Ratio
+37% / +39%In 3 years sales changed by +37% while total assets changed by +39%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
0.3×Debt due within a year is covered 0.3 times by its yearly operating cash.
Lower than 67% of Healthcare companies in Japan.
Cash Cushion Ratio
+10%Cash, after subtracting all debt, equals 10% of its market value (net cash).
Higher than 61% of Healthcare companies in Japan.
Tangible Assets Ratio
100%Of every ¥100 the company owns, ¥100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 81% of Healthcare companies in Japan.
Tangible Net Worth Ratio
99%Of every ¥100 of net worth, ¥99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 76% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Softmax Co., Ltd owes ¥0.54 for every ¥1 it owns. Net profit rose 19% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
12.9Investors pay ¥12.9 for every ¥1 of Softmax Co., Ltd's yearly profit, lower than 63% of Healthcare companies in Japan.
P/B ratio
1.69The share price is 1.69 times Softmax Co., Ltd's book value per share, higher than 56% of Healthcare companies in Japan.
Market cap
¥6.7 BThe total market value of all of Softmax Co., Ltd's shares at today's price (share price × number of shares), smaller than 71% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥3.9 BWhat Softmax Co., Ltd would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥163.61Net worth divided by the number of shares. The share price of ¥277.00 is 1.7 times this, which is the P/B above.
Return on equity (ROE)
13.6%Softmax Co., Ltd earned 13.6% on its shareholders' money over the last year, higher than 79% of Healthcare companies in Japan.
Owes vs Owns
0.54×Softmax Co., Ltd owes ¥0.54 for every ¥1 it owns (moderate), higher than 68% of Healthcare companies in Japan.
Dividend yield
3.60%Softmax Co., Ltd pays 3.60% of its share price as dividends a year, higher than 75% of dividend-paying Healthcare companies in Japan.
Revenue growth
+28%Revenue rose 28% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Profit growth
+19%Net profit rose 19% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Profit margin
8.3%Softmax Co., Ltd keeps ¥8 of every ¥100 of revenue as net profit.
Cash quality
0.7×Cash from Softmax Co., Ltd's business was 0.7× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.
Interest cover
63.6×Softmax Co., Ltd's operating profit covered its interest costs 63.6 times in the year to Dec 2025.
Cash vs debt
Net cashSoftmax Co., Ltd held ¥639 M more cash than debt (net cash) at Dec 2025.
Questions
What is Softmax Co., Ltd's P/E ratio?
Investors pay ¥12.9 for every ¥1 of Softmax Co., Ltd's yearly profit, lower than 63% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Softmax Co., Ltd: ¥6.7 B ÷ ¥3.9 B (30 Jun 2026) = 1.7.
What is Softmax Co., Ltd's return on equity?
Softmax Co., Ltd earned 13.6% on its shareholders' money over the last year, higher than 79% of Healthcare companies in Japan.
How much does Softmax Co., Ltd owe compared with what it owns?
Softmax Co., Ltd owes ¥0.54 for every ¥1 it owns (moderate), higher than 68% of Healthcare companies in Japan.
Does Softmax Co., Ltd pay a dividend?
Yes. Softmax Co., Ltd pays 3.60% of its share price as dividends a year, higher than 75% of dividend-paying Healthcare companies in Japan.
Is Softmax Co., Ltd's revenue growing?
Revenue rose 28% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.